FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2267220552> ?p ?o ?g. }

• W2267220552 endingPage "2336" @default.
• W2267220552 startingPage "2331" @default.
• W2267220552 abstract "To evaluate cisplatin-fluorouracil exclusive chemotherapy (EC) for T1-T3N0 glottic squamous cell carcinoma complete clinical responders (CCR) after cisplatin-fluorouracil induction chemotherapy (IC).A retrospective analysis was performed of 58 patients with T1-T3N0 glottic squamous cell carcinoma CCR after IC consecutively managed at our department between 1985 and 1992. Twenty-one CCR were managed with EC. Thirty-seven CCR were managed with IC and a conventional laryngeal-preservation modality. Analyses of survival, local control, nodal recurrence, distant metastasis, and metachronous second primary tumor were performed using the Kaplan-Meier actuarial life-table method. In CCR managed with EC, the independent factors of age, tumor classification, exact tumor location, true vocal cord motion, arytenoid cartilage motion, total dosage of drugs delivered, and number of courses received were tested for potential correlation with survival, local recurrence, nodal recurence, and distant metastasis.The 5-year survival, local control, nodal recurrence, distant metastasis, and metachronous second primary tumor rates in CCR managed with EC were 95.2%, 70.7%, 0%, 0%, and 14.3%, respectively. The 5-year rates of survival, local control, nodal recurrence, distant metastasis, and metachronous second primary tumor in CCR managed with IC and a conventional laryngeal-preservation modality were 86.1%, 97%, 2.7%, 6%, and 14.5%, respectively. Local recurrence was statistically more likely in CCR managed with EC (P = .002). Local recurrence in CCR managed with EC was always salvaged with partial laryngectomy or radiation therapy, which resulted in an overall 100% local control and laryngeal-preservation rate within this group. In CCR managed with EC, none of the variables analyzed was statistically related to survival, local recurrence, nodal recurrence, or distant metastasis.The present retrospective studies demonstrated that within T1-T3N0 glottic squamous cell carcinoma CCR, there is clearly a significant subset of patients with chemocurable tumors who achieved both perfect preservation of structure-supporting voice and long-term survival after EC. Careful monthly follow-up evaluation allowed for timely successful salvage of local recurrence after EC without the need for total laryngectomy. Such management did not appear to increase the risk for subsequent nodal failure, subsequent distant metastasis, or reduced survival." @default.
• W2267220552 created "2016-06-24" @default.
• W2267220552 creator A5021036926 @default.
• W2267220552 creator A5030823178 @default.
• W2267220552 creator A5032111088 @default.
• W2267220552 creator A5060245188 @default.
• W2267220552 creator A5077898521 @default.
• W2267220552 creator A5081749963 @default.
• W2267220552 date "1996-08-01" @default.
• W2267220552 modified "2023-10-16" @default.
• W2267220552 title "Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results." @default.
• W2267220552 cites W1820173822 @default.
• W2267220552 cites W1829456055 @default.
• W2267220552 cites W1965275407 @default.
• W2267220552 cites W1972738587 @default.
• W2267220552 cites W1979300931 @default.
• W2267220552 cites W1984487367 @default.
• W2267220552 cites W1995262470 @default.
• W2267220552 cites W2000300263 @default.
• W2267220552 cites W2004705063 @default.
• W2267220552 cites W2006534438 @default.
• W2267220552 cites W2007443905 @default.
• W2267220552 cites W2014735254 @default.
• W2267220552 cites W2014919678 @default.
• W2267220552 cites W2017819643 @default.
• W2267220552 cites W2022988063 @default.
• W2267220552 cites W2027529868 @default.
• W2267220552 cites W2054144111 @default.
• W2267220552 cites W2071119731 @default.
• W2267220552 cites W2072875209 @default.
• W2267220552 cites W2076668534 @default.
• W2267220552 cites W2086841529 @default.
• W2267220552 cites W2086855064 @default.
• W2267220552 cites W2090471119 @default.
• W2267220552 cites W2167622031 @default.
• W2267220552 cites W2229127382 @default.
• W2267220552 cites W2406213538 @default.
• W2267220552 cites W2562414697 @default.
• W2267220552 doi "https://doi.org/10.1200/jco.1996.14.8.2331" @default.
• W2267220552 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8708725" @default.
• W2267220552 hasPublicationYear "1996" @default.
• W2267220552 type Work @default.
• W2267220552 sameAs 2267220552 @default.
• W2267220552 citedByCount "46" @default.
• W2267220552 countsByYear W22672205522012 @default.
• W2267220552 countsByYear W22672205522013 @default.
• W2267220552 countsByYear W22672205522014 @default.
• W2267220552 countsByYear W22672205522016 @default.
• W2267220552 countsByYear W22672205522018 @default.
• W2267220552 countsByYear W22672205522019 @default.
• W2267220552 crossrefType "journal-article" @default.
• W2267220552 hasAuthorship W2267220552A5021036926 @default.
• W2267220552 hasAuthorship W2267220552A5030823178 @default.
• W2267220552 hasAuthorship W2267220552A5032111088 @default.
• W2267220552 hasAuthorship W2267220552A5060245188 @default.
• W2267220552 hasAuthorship W2267220552A5077898521 @default.
• W2267220552 hasAuthorship W2267220552A5081749963 @default.
• W2267220552 hasConcept C121608353 @default.
• W2267220552 hasConcept C126322002 @default.
• W2267220552 hasConcept C141071460 @default.
• W2267220552 hasConcept C143998085 @default.
• W2267220552 hasConcept C2776611710 @default.
• W2267220552 hasConcept C2776694085 @default.
• W2267220552 hasConcept C2778239845 @default.
• W2267220552 hasConcept C2779013556 @default.
• W2267220552 hasConcept C2780283643 @default.
• W2267220552 hasConcept C2780456651 @default.
• W2267220552 hasConcept C2780474809 @default.
• W2267220552 hasConcept C2781157581 @default.
• W2267220552 hasConcept C2781447300 @default.
• W2267220552 hasConcept C509974204 @default.
• W2267220552 hasConcept C71924100 @default.
• W2267220552 hasConceptScore W2267220552C121608353 @default.
• W2267220552 hasConceptScore W2267220552C126322002 @default.
• W2267220552 hasConceptScore W2267220552C141071460 @default.
• W2267220552 hasConceptScore W2267220552C143998085 @default.
• W2267220552 hasConceptScore W2267220552C2776611710 @default.
• W2267220552 hasConceptScore W2267220552C2776694085 @default.
• W2267220552 hasConceptScore W2267220552C2778239845 @default.
• W2267220552 hasConceptScore W2267220552C2779013556 @default.
• W2267220552 hasConceptScore W2267220552C2780283643 @default.
• W2267220552 hasConceptScore W2267220552C2780456651 @default.
• W2267220552 hasConceptScore W2267220552C2780474809 @default.
• W2267220552 hasConceptScore W2267220552C2781157581 @default.
• W2267220552 hasConceptScore W2267220552C2781447300 @default.
• W2267220552 hasConceptScore W2267220552C509974204 @default.
• W2267220552 hasConceptScore W2267220552C71924100 @default.
• W2267220552 hasIssue "8" @default.
• W2267220552 hasLocation W22672205521 @default.
• W2267220552 hasLocation W22672205522 @default.
• W2267220552 hasOpenAccess W2267220552 @default.
• W2267220552 hasPrimaryLocation W22672205521 @default.
• W2267220552 hasRelatedWork W1990604199 @default.
• W2267220552 hasRelatedWork W2023463542 @default.
• W2267220552 hasRelatedWork W2088505787 @default.
• W2267220552 hasRelatedWork W2139450301 @default.
• W2267220552 hasRelatedWork W2143135236 @default.
• W2267220552 hasRelatedWork W2157789193 @default.

• next